If John Legh Winser, CEO, recently thought fit to buy:
200,000 shares @ $1.61 per share (ie., a
total consideration of $322,000)
28,000 shares @ $1.677388 per share (ie., a
total consideration of $46,966.86)
300,000 shares @ $1.645 per share (ie., a
total consideration of $493,500.00
then the current price is a steal. I would like to know how the WA business is tracking? I am surprised that somebody like Lindsay Fox does not buy out KSC, perhaps by purchasing the interests of the late Alan Scott.
Pioupiou
- Forums
- ASX - By Stock
- possible cheap buying opportunities
If John Legh Winser, CEO, recently thought fit to buy: 200,000...
Add KSC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.49 |
Change
0.060(1.75%) |
Mkt cap ! $477.6M |
Open | High | Low | Value | Volume |
$3.46 | $3.49 | $3.46 | $59 | 17 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2 | $3.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.49 | 198 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4017 | 1.700 |
1 | 3267 | 1.690 |
1 | 10147 | 1.670 |
1 | 721 | 1.360 |
1 | 800 | 1.350 |
Price($) | Vol. | No. |
---|---|---|
1.865 | 5200 | 2 |
1.870 | 4000 | 1 |
2.000 | 25000 | 1 |
2.250 | 19000 | 1 |
2.270 | 4405 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
KSC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
Previous Video
Next Video
SPONSORED BY The Market Online